ROTE WILLIAM E.

Chief Research Officer

ROTE WILLIAM E. has filed 6 SEC Form 4 filings (19 transaction rows) across 1 company, with disclosures dating back to 2025. 6 of those filings fall inside the rolling window. Most recent filing: Sep 18, 2026.

On the most recent filing, ROTE WILLIAM E. is listed as Chief Research Officer at Travere Therapeutics, Inc. Inside the rolling window, ROTE WILLIAM E. reported no open-market purchases and 6 open-market sales totaling $16.4M in TVTX. The largest disclosed transaction in the window is a sale of 112,850 TVTX shares on Sep 16, 2026, worth $7.1M.

Companies traded

Other insiders at TVTX

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$16.4M

reported sales (SEC code S)

Companies

1

in the rolling window

Source
TVTXSale$6.0MSep 18SEC ↗
TVTXSale$7.1MSep 18SEC ↗
TVTXSale$121KMay 7SEC ↗
TVTXSale$356KApr 23SEC ↗
TVTXSale$409KFeb 3SEC ↗
TVTXSale$2.4MDec 29SEC ↗
Showing 1–6 of 6
1 / 1

Frequently asked questions

How many SEC Form 4 filings has ROTE WILLIAM E. made?

ROTE WILLIAM E. has filed 6 SEC Form 4 filings (19 transaction rows) across 1 company since 2025.

Which companies does ROTE WILLIAM E. trade?

ROTE WILLIAM E. has filed SEC Form 4 disclosures for 1 company, including TVTX.

When was ROTE WILLIAM E.'s most recent SEC Form 4 filing?

ROTE WILLIAM E.'s most recent SEC Form 4 filing on Tracefour is dated Sep 18, 2026.

What is ROTE WILLIAM E.'s job title?

On the most recent SEC Form 4 filings tracked by Tracefour, ROTE WILLIAM E. is listed as Chief Research Officer.

What is ROTE WILLIAM E.'s total buy and sell value in the current window?

Inside the rolling retention window, ROTE WILLIAM E. bought $0 and sold $16.4M based on SEC Form 4 filings.

What was ROTE WILLIAM E.'s largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 112,850 TVTX shares on 2026-09-16, worth $7.1M, per SEC Form 4 filings.